Skip to main content
European Journal of Human Genetics logoLink to European Journal of Human Genetics
letter
. 2010 Nov 17;19(2):123–124. doi: 10.1038/ejhg.2010.192

Does the HSD17B10 gene escape from X-inactivation?

Xue-Ying He 1, Carl Dobkin 2, Song-Yu Yang 1,*
PMCID: PMC3025801  PMID: 21081971

We read with great interest the recent report by Garcia-Villoria et al1 regarding the expression of the HSD17B10 gene from the inactive X chromosome that was published in the European Journal of Human Genetics (Advance online publication, 28 July 2010; doi:10.1038/ejhg.2010.118).

It had been reported previously that a cluster of six genes, including the HSD17B10 (formerly HADH2) gene in Xpl 1.2, escapes X-inactivation.2 Subsequently, Carrel and Willard, in a more detailed study,3 showed that the escape of the HSD17B10 gene from X-inactivation is not complete. The expression of the HSD17B10 gene and the surrounding genes from the inactive X chromosome (Xi) is summarized in Figure 1 (adapted from Ref. Yang et al4).

Figure 1.

Figure 1

Expression of transcripts of the HSD17B10 and surrounding genes from inactive X (Xi) hybrids. Samples scored as positive are expressed at least >10% of the Xa levels, and their number is shown as the numerator. The total number of hybrids tested is shown as the denominator. Genes with mutation(s)5 or copy number variation (CNV)6 causing mental retardation are marked with asterisk.

Two female patients heterozygous for HSD10 deficiency were the subjects of this present study1 in which skin fibroblast cultures were examined to determine the inactivation ratio of the normal and mutated X chromosomes. It appears that these studies were performed on cultures originating from a single biopsy from each patient. Mosaicism due to lyonization results in relatively large patches of skin with the same inactivated X chromosome, commonly illustrated by the coloration of calico cats. Thus, an analysis of cells from a single biopsy is probably not adequate to determine the X inactivation ratio. Analysis of a blood sample might be more informative.

In addition, the standard deviation (SD) appears to be relatively large, that is, >15% of the mean value in most cases. This limitation makes it unlikely that partial (12%, Carrel and Willard3) escape of the HSD17B10 gene from X-inactivation in the first female patient would be detectable. Moreover, although monoallelic expression in one of the cell lines indicates that this gene is subject to inactivation, lack of data from other tissue samples makes the inference of widespread monoallelic expression of the HSD17B10 gene in the second female patient less than convincing. The statement that ‘as the girl was severely affected, a similar unfavorable X-inactivation in other tissues could be expected'1 does not suffice for correcting the defect in data. The conclusion that ‘the HSD17B10 gene does not escape X-inactivation as has been reported previously' is not adequately supported by the data included in this publication.

Acknowledgments

This work was supported in part by the NYS Office For People With Developmental Disabilities.

The authors declare no conflict of interest.

References

  1. Garcia-Villoria J, Gort L, Madrigl I, et al. X-inactivation of HSD17B10 revealed by cDNA analysis in two female patients with 17beta-hydroxysteroid dehydrogenase 10 deficiency. Eur J Hum Genet. 2011;19:124. doi: 10.1038/ejhg.2010.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Miller AP, Willard HF. Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. Proc Natl Acad Sci USA. 1998;95:8709–8714. doi: 10.1073/pnas.95.15.8709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–404. doi: 10.1038/nature03479. [DOI] [PubMed] [Google Scholar]
  4. Yang SY, He XY, Miller D. HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids. Mol Genet Metab. 2007;92:36–42. doi: 10.1016/j.ymgme.2007.06.001. [DOI] [PubMed] [Google Scholar]
  5. Yang SY, He XY, Olpin SE, et al. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism. Proc Natl Acad Sci USA. 2009;106:14820–14824. doi: 10.1073/pnas.0902377106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Froyen G, Corbett M, Vandewalle J, et al. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet. 2008;82:432–443. doi: 10.1016/j.ajhg.2007.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Journal of Human Genetics are provided here courtesy of Nature Publishing Group

RESOURCES